Search

Your search keyword '"SOMANI, ALLY-KHAN"' showing total 323 results

Search Constraints

Start Over You searched for: Author "SOMANI, ALLY-KHAN" Remove constraint Author: "SOMANI, ALLY-KHAN"
323 results on '"SOMANI, ALLY-KHAN"'

Search Results

2. Integrating the 40-Gene Expression Profile (40-GEP) Test Improves Metastatic Risk-Stratification Within Clinically Relevant Subgroups of High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients

4. Development of international clinical practice guidelines: benefits, limitations, and alternative forms of international collaboration

5. Principles for developing and adapting clinical practice guidelines and guidance for pandemics, wars, shortages, and other crises and emergencies: the PAGE criteria

7. The 40-gene Expression Profile (40-GEP) Test Identifies Cutaneous Squamous Cell Carcinoma (cSCC) Patients at High Risk of Metastasis within Lower-Staged Tumors to Better Guide Treatment Decisions

8. Broad versus narrow clinical practice guidelines: avoiding rules for the high risk 1%

10. Validation of a 40-gene expression profile test to predict metastatic risk in localized high-risk cutaneous squamous cell carcinoma

14. Incorporating the 40-Gene Expression Profile (40-GEP) Test within Each Clinicopathologic Staging System Improves Metastatic Risk-Stratification in Patients Diagnosed with Cutaneous Squamous Cell Carcinoma (cSCC) and One or More High Risk Factors

18. Sebaceous carcinoma: evidence-based clinical practice guidelines

20. Contributors

21. Chemical Peels

24. Practical applications of small intestine submucosa extracellular matrix (SIS-ECM) an expert panel consensus

31. Use of the 40-gene Expression Profile (40-GEP) Test in Medicareeligible Patients Diagnosed with Cutaneous Squamous Cell Carcinoma (cSCC) to Guide Adjuvant Radiation Therapy (ART) Decisions Leads to a Significant Reduction in Healthcare Costs.

41. Casting a wider net: Mohs micrographic surgery for retiform hemangioendothelioma.

45. Enhanced metastatic risk assessment in cutaneous squamous cell carcinoma with the 40-gene expression profile test

47. Gene expression profiling for metastatic risk in head and neck cutaneous squamous cell carcinoma

49. 25726 Prospective adjuvant therapy trial design using a prognostic 40-gene expression profile (40-GEP) test for high-risk cutaneous squamous cell carcinoma (cSCC) and BWH staging-based risk assessment

Catalog

Books, media, physical & digital resources